Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Centessa Pharmaceuticals (CNTA) Shares Issued (2022 - 2026)

Centessa Pharmaceuticals has reported Shares Issued over the past 4 years, most recently at $14.3 million for Q4 2025.

  • Quarterly Shares Issued rose 168.29% to $14.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.4 million through Dec 2025, up 90.27% year-over-year, with the annual reading at $21.4 million for FY2025, 90.27% up from the prior year.
  • Shares Issued was $14.3 million for Q4 2025 at Centessa Pharmaceuticals, up from $3.6 million in the prior quarter.
  • Over five years, Shares Issued peaked at $14.3 million in Q4 2025 and troughed at -$405000.0 in Q3 2022.
  • The 4-year median for Shares Issued is $820000.0 (2024), against an average of $2.3 million.
  • Year-over-year, Shares Issued tumbled 82.86% in 2023 and then skyrocketed 6583.33% in 2024.
  • A 4-year view of Shares Issued shows it stood at -$405000.0 in 2022, then soared by 129.14% to $118000.0 in 2023, then surged by 4427.12% to $5.3 million in 2024, then soared by 168.29% to $14.3 million in 2025.
  • Per Business Quant, the three most recent readings for CNTA's Shares Issued are $14.3 million (Q4 2025), $3.6 million (Q3 2025), and $1.7 million (Q2 2025).